A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
about
Isolation of the thrombospondin membrane receptorBlasts from the pastPlatelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responsesSwing-out of the β3 hybrid domain is required for αIIbβ3 priming and normal cytoskeletal reorganization, but not adhesion to immobilized fibrinogenClosed headpiece of integrin IIb 3 and its complex with an IIb 3-specific antagonist that does not induce openingThree-dimensional reconstruction of intact human integrin IIb 3: new implications for activation-dependent ligand bindingLipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activityAntiplatelet drugsPurification and partial characterization of CD9 antigen of human plateletsAdhesion efficiency, platelet density and size.A novel ultrasound-based method to evaluate hemostatic function of whole bloodChemoproteomic discovery of AADACL1 as a regulator of human platelet activation.Laser scanning cytometry: a novel method for the detection of platelet--endothelial cell adhesion.Platelet glycoprotein IIb/IIIa receptor antagonists.The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.Antigenic differences between human platelets and megakaryocytes.Separation of important new platelet glycoproteins (GPIa, GPIc, GPIc*, GPIIa and GMP-140) by f.p.l.c. Characterization by monoclonal antibodies and gas-phase sequencing.Thrombosis and antithrombotic therapy in womenProtein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities.Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets.The importance of N-glycosylation on β3 integrin ligand binding and conformational regulationEffects of limiting extension at the alphaIIb genu on ligand binding to integrin alphaIIbbeta3.Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogenPrevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I--Pathophysiological and pharmacological features.Platelet adhesion receptors: novel targets for anti-thrombotic therapy.Glanzmann thrombasthenia secondary to a Gly273-->Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb.Adenosine diphosphate-induced aggregation of human platelets in flow through tubes. II. Effect of shear rate, donor sex, and ADP concentrationThe platelet: life on the razor's edge between hemorrhage and thrombosis.Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder.Identification of the thrombin receptor on human platelets by chemical crosslinking.Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells.A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complexInvolvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
P2860
Q24314835-3442D27B-CEA8-440C-BCF9-69E71D1FB606Q24563415-A517E47D-931E-4397-9852-2EFD8922AA11Q24650652-510B4876-94CE-44AC-B36F-EDD7005A01B8Q27301036-99D6FFCD-62D9-4630-99F9-875796AB64FAQ27663824-0A9C2EC5-89E4-4C39-8B7D-264F214DC61AQ27680395-7DC3867B-E335-498A-9BDC-1D310F8B237EQ28156404-9AE3D3E2-3E34-4123-B341-BF9683DBC5FEQ28194430-C29DF4FC-8151-4CD6-811E-EA8CF7AE82EFQ28288816-491FF622-286B-4FB4-A555-D43B2C00A05DQ30310976-3C263AF9-D8B7-4BFC-8791-98180659047EQ30433609-BB948644-68D8-4D83-B558-B11178813867Q30573816-BFD2AB84-9F63-4E31-A1AC-DAAE339423AFQ30984034-9D993D81-5E66-440B-8047-F3E85D602ECAQ33336362-E1C18746-370D-4F67-AE88-AA0FEBC7C933Q33367036-E3B15A0F-AC15-4476-BE2D-2D2A49A87C6BQ33381441-ACBDA9F0-8C67-4E76-A178-045EAD53B536Q33444536-F7EA4E3C-2468-4764-AB08-754EFC89F8C2Q33449399-CB7BC8AA-C998-4ECA-B132-306BA1495AA0Q33453656-D271D483-BCC6-4332-8767-F19EFD308F84Q33470320-AF239FFB-32A5-473A-BBE2-A3F67627005AQ33569283-57EB8BA9-1A1B-440F-B1D3-53C21EF038BEQ33835575-38E0743F-F95F-46E1-AF75-06EA83BB9649Q33846628-0B5D2028-120A-49BC-87B5-B1EF53638F8FQ33875329-C059AFBE-981D-420C-893E-6F5EBA097F2DQ33885186-48C0C8F1-82A7-43D5-A7A0-6FCB63944189Q33909935-9CB48A28-13D3-489D-884F-4D20E74F61D0Q33931454-331740CF-82B7-4D00-8C02-A9D1DA26491AQ33951293-690802AC-6716-458D-B334-9C534FCFA761Q34119585-2D142A63-560C-430C-B74F-4F26AF3F9455Q34125159-1274E571-C67C-4863-A5D2-34F6546AE1ABQ34175105-2595D86F-4264-45FA-9358-27559D7994A7Q34177216-A7D26941-55CD-4DF4-BB06-5CB795EB151AQ34208569-A8771E96-4CFB-4074-906B-A0355369F0EDQ34518712-53D34000-8BBD-49F2-866D-6CA80A7A7FB0Q34520405-C95124D6-72DE-4D02-9ECA-EA0AE3326965Q34521638-CAEA4233-2A69-4353-ACA6-DB651D1CA3AEQ34528200-3A758FAD-342B-4665-AE44-9DC792ADAA7EQ34536168-36643F26-F97A-4B10-80FC-91FC6E69C929Q34541247-C7B6403D-2F36-4F54-B9F7-6AD14410B707Q34549309-A9A41FE8-DB77-4180-B5F1-02A7F21A2ED7
P2860
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa
description
1983 nî lūn-bûn
@nan
1983 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@ast
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@en
type
label
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@ast
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@en
prefLabel
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@ast
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@en
P2093
P2860
P356
P1476
A murine monoclonal antibody t ...... glycoproteins IIb and/or IIIa
@en
P2093
B S Coller
C A Sullivan
E I Peerschke
L E Scudder
P2860
P304
P356
10.1172/JCI110973
P407
P577
1983-07-01T00:00:00Z